These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9513540)

  • 1. [Sudden death due to genetic and biochemical disorders--hypertropic cardiomyopathy].
    Nishi H
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):3-9. PubMed ID: 9513540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sarcomere gene mutations--a cause of hypertrophic cardiomyopathy].
    Kuusisto J; Jääskeläinen P; Laakso M
    Duodecim; 1999; 115(9):997-8. PubMed ID: 11877825
    [No Abstract]   [Full Text] [Related]  

  • 3. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children.
    Greber-Platzer S; Marx M; Fleischmann C; Suppan C; Dobner M; Wimmer M
    J Mol Cell Cardiol; 2001 Jan; 33(1):141-8. PubMed ID: 11133230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 7. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial hypertrophic cardiomyopathy.
    Piano MR
    J Cardiovasc Nurs; 1999 Jul; 13(4):46-58. PubMed ID: 10386271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine model for hypertrophic cardiomyopathy.
    Vikstrom KL; Factor SM; Leinwand LA
    Z Kardiol; 1995; 84 Suppl 4():49-54. PubMed ID: 8585273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: can the horse be put back in the barn?
    Wheeler MT; Ashley EA
    J Am Coll Cardiol; 2015 Feb; 65(6):570-2. PubMed ID: 25677316
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudden death in hypertrophic cardiomyopathy.
    Watkins H
    N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural effects of the slow/b-cardiac myosin heavy chain R453C mutation in cardiac and skeletal muscle.
    Tajsharghi H; Fyhr IM
    Scand Cardiovasc J; 2008 Apr; 42(2):153-6. PubMed ID: 18365899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic screening and risk assessment in hypertrophic cardiomyopathy.
    MacRae CA; Ellinor PT
    J Am Coll Cardiol; 2004 Dec; 44(12):2326-8. PubMed ID: 15607393
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genotype-phenotype correlations in familial hypertrophic cardiomyopathy].
    Anan R; Niimura H; Tei C
    Nihon Rinsho; 2000 Jan; 58(1):134-40. PubMed ID: 10885301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [mRNA detection of beta-myosin heavy chain gene in the autopsy cases of hypertrophic cardiomyopathy].
    Sato H; Fujiwara S; Terada K; Sato Y; Tsuto Y; Ikoma T; Aihara H; Yanagisawa A; Horiike T
    Nihon Hoigaku Zasshi; 2000 Nov; 54(3):408-13. PubMed ID: 11218759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age.
    Havndrup O; Bundgaard H; Andersen PS; Larsen LA; Vuust J; Kjeldsen K; Christiansen M
    Am J Cardiol; 2001 Jun; 87(11):1315-7. PubMed ID: 11377367
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypertrophic cardiomyopathy: never-ending complexity].
    Navarro-López F
    Rev Esp Cardiol; 2006 Oct; 59(10):994-6. PubMed ID: 17125707
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and genetical heterogeneity of familial hypertrophic cardiomyopathy.
    Hengstenberg C; Carrier L; Schwartz K; Maisch B
    Herz; 1994 Apr; 19(2):84-90. PubMed ID: 8194836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting risk stratification in hypertrophic cardiomyopathy: do we need to start from scratch?
    Lee MS; Macrae CA
    Heart Rhythm; 2012 Jan; 9(1):64-5. PubMed ID: 22019864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.